Related Experiment Videos
Telomere dynamics in response to chemotherapy
1Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.
Current Molecular Medicine
|June 25, 2005
Summary
Chemotherapy can shorten telomeres in healthy cells, potentially impacting tissue regeneration and long-term health. This review explores how anticancer drugs affect telomeres and the consequences for patients.
Area of Science:
- Oncology
- Cell Biology
- Genetics
Background:
- Cancer treatment relies on chemotherapy, targeting rapidly dividing cells.
- Chemotherapy causes side effects in healthy, rapidly dividing tissues.
- Long-term effects of chemotherapy on healthy tissues are increasingly recognized.
Purpose of the Study:
- To review how anticancer drugs modulate telomeres.
- To discuss the consequences of chemotherapy-induced telomere shortening in healthy tissues.
- To examine the impact on long-term tissue replicative potential.
Main Methods:
- Literature review of chemotherapy's effects on telomeres.
- Analysis of telomere dynamics in healthy regenerative tissues post-chemotherapy.
- Discussion of cellular aging and chromosomal stability in relation to telomere length.
Main Results:
- Chemotherapy treatment is associated with shorter telomeres in patients compared to controls.
- Accelerated telomere shortening occurs in healthy regenerative tissues after chemotherapy.
- Telomere length is a potential biomarker for long-term chemotherapy toxicity.
Conclusions:
- Chemotherapy can lead to premature telomere shortening in healthy tissues.
- This shortening may compromise the long-term regenerative capacity of tissues.
- Further research is needed to understand and mitigate these long-term effects.